首页 | 本学科首页   官方微博 | 高级检索  
检索        

纳洛酮联合氨茶碱治疗早产儿原发性呼吸暂停42例
引用本文:周志梅,花少栋,陈少君.纳洛酮联合氨茶碱治疗早产儿原发性呼吸暂停42例[J].中国煤炭工业医学杂志,2004,7(10):920-921.
作者姓名:周志梅  花少栋  陈少君
作者单位:526060,广东省肇庆市第二人民医院儿科
摘    要:目的 观察纳洛酮联合氨茶碱治疗早产儿原发性呼吸暂停的疗效。方法  81例入选患儿随机分成二组 ,二组患儿均给予氨茶碱等治疗 ,观察组在此基础上加用纳洛酮治疗 ,疗程 1周 ,观察二组患儿原发性呼吸暂停发生的时间和次数、心率 (HR)、经皮血氧饱和度 (SpO2 )等 ,判断疗效 ,进行统计学分析。结果 对照组总有效率 79.49% ,观察组总有效率 95 .2 4 % ,经统计学处理 ,差异有统计学意义 ,观察组显效的例数 (32 / 4 2 )也优于对照组 (1 7/ 39) (P <0 .0 1 )。结论 纳洛酮联合氨茶碱治疗早产儿原发性呼吸暂停的疗效显著 ,不良反应少 ,值得临床推广。

关 键 词:呼吸暂停  纳洛酮  氨茶碱  早产儿
文章编号:1007-9564(2004)10-0920-02
修稿时间:2004年4月1日

NALOXONE AND AMINOPHYLLINE IN PRIMARY PREMATURE APNEA:A REPORT OF 42 CASES
Zhou Zhimei,Hua Shaodong,Chen Shaojun.NALOXONE AND AMINOPHYLLINE IN PRIMARY PREMATURE APNEA:A REPORT OF 42 CASES[J].Chinese Journal of Coal Industry Medicine,2004,7(10):920-921.
Authors:Zhou Zhimei  Hua Shaodong  Chen Shaojun
Institution:Zhou Zhimei,Hua Shaodong,Chen Shaojun.Department of Pediatrics,The Second People's Hospital of Zhaoqing,Zhaoqing 526060,China
Abstract:Objective To observe the clinical outcome of Naloxone and Aminophylline in treating primary premature apnea. Methods 81 premature infants were randomly divided into treatment group(n=42) and control group(n=39). Subjects in the control group were given basic treatment and Aminophylline. Subjects in the treatment group were treated with medication in the control group and Naloxone.Duration of treatment was one week.The clinical outcome was measured with times and duration of apnea,heart rate,SpO 2. The statistical analysis was performed with chis-square and t-test. Results The total effective rate in the control group and the treatment group were 79.49% and 95.24%.Effective cases in treatment group(32/42) was significantly higher than those of control group(17/39)(P<0.01). Conclusion The combination of Naloxone and Aminophylline is effective in treatment of premature apnea,and has less side effects.
Keywords:apnea  naloxone  aminophylline  premature infant
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号